RE-186 labeled 16.88 IgM and 88BV59 IgG human antibody studies to assess potential for radioimmunotherapy
Journal Article
·
· Journal of Nuclear Medicine
OSTI ID:197976
- Virginia Mason Medical Center, Seattle, WA (United States)
Two studies with Re-186-MAG{sub 2}GABA labeled human antibodies were carried out to assess feasibility for radioimmunotherapy. Antibodies 16.88 and 88BV59 react with different epitopes of CTA 16.88, a tumor associated antigen of colorectal carcinoma. In a phase I dose escalation study, 14 patients received 60 mg/m{sup 2} 16.88 IgM MoAb. The dose of Re-186 ranged from 25 mCi/m{sup 2} to 210 mCi/m{sup 2} divided into 3 weekly infusions. In a pilot study with 88BV59, a human IgG3k MoAb, 20 mg antibody was labeled with 25 mCi/m{sup 2} Re-186 and administered to 4 patients with colon carcinoma. Tumor targeting was seen in 12 of 14 patients with 16.88 and all 4 patients with 88BV59. Retention of antibody at the tumor was longer with 88BV59. One patient developed a rash. No other acute or delayed toxicities were observed. Human anti-human antibody did not develop in any patient. The slower metabolism of the 88BV59 IgG suggests that this form of immunoconjugate merits further investigation for use in radioimmunotherapy.
- OSTI ID:
- 197976
- Report Number(s):
- CONF-940605--
- Journal Information:
- Journal of Nuclear Medicine, Journal Name: Journal of Nuclear Medicine Journal Issue: Suppl.5 Vol. 35; ISSN 0161-5505; ISSN JNMEAQ
- Country of Publication:
- United States
- Language:
- English
Similar Records
Use of second antibody in radioimmunotherapy
Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma
In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: Safety, sensitivity, and preliminary clinical results
Journal Article
·
Wed Dec 31 23:00:00 EST 1986
· NCI Monogr.; (United States)
·
OSTI ID:6518729
Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma
Journal Article
·
Wed Feb 28 23:00:00 EST 1990
· Journal of Clinical Oncology; (USA)
·
OSTI ID:6969352
In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: Safety, sensitivity, and preliminary clinical results
Journal Article
·
Sat Mar 31 23:00:00 EST 1990
· Radiology; (USA)
·
OSTI ID:6969104